Сhronically Administered BDNF Dipeptide Mimetic GSB-106 Prevents the Depressive-like Behavior and Memory Impairments after Transient Middle Cerebral Occlusion in Rats

Conclusion. The BDNF dipeptide mimetic GSB-106 is promising for further development as a drug for the treatment of poststroke neuropsychiatric disorders.PMID:36597610 | DOI:10.2174/1381612829666230103161824

Source: Current Pharmaceutical Design - January 4, 2023 Category: Drugs & Pharmacology Authors: Polina Yu Povarnina Tatyana A Antipova Ilya O Logvinov Tatiana A Gudasheva Sergey B Seredenin Source Type: research